About 7 results found for searched term "MIRA-1" (0.157 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6958 | MIRA-1 | p53 |
| NSC 19630; MIRA1 | ||
| MIRA-1 is a maleimide analogue. MIRA-1 can induce apoptosis in mutant p53 cells via restoration of p53-dependent transcriptional transactivation. | ||
| M50883 | Miraculin (1-20) | Others |
| Miraculin (1-20) is a peptide, comprised of 20 amino acids. | ||
| M2069 | Mirabegron | Adrenergic Receptor |
| YM-178 | ||
| Mirabegron (YM178) is a potent and selective β(3)-adrenoceptor agonist with EC50 of 22.4 nM. | ||
| M2824 | Lumiracoxib | COX |
| COX-189 | ||
| Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. | ||
| M8909 | Miransertib | Akt |
| ARQ 092 | ||
| Miransertib, also known as ARQ 092, is an oral activie, potent and selective AKT inhibitor with IC50 values: 5.0 nM (AKT1); 4.5 nM (AKT2); 16 nM (AKT3). | ||
| M11229 | Miransertib hydrochloride | Akt |
| ARQ-092 hydrochloride | ||
| Miransertib hydrochloride (ARQ-092 Hydrochloride) is a potent, orally active, selective and allosteric Akt inhibitor with an IC50 of 2.7 nM for Akt1, Akt2, and Akt3, respectively. 14 nM and 8.1 nM. Miransertib hydrochloride is an effective inhibitor of AKT1-E17K mutant protein, and can be used in the study of PI3K/ AkT-driven tumors and Proteus syndrome. Miransertib hydrochloride effectively inhibited Leishmania. | ||
| M42003 | Zomiradomide | IRAK |
| IRAK degrader-1 | ||
| Zomiradomide (IRAK degrader-1) is a potent IRAK degrader. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
